the changing standard of care in dlbcl
Published 1 month ago • 65 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:53
autohct in dlbcl in the car-t era
-
7:16
changes in the classification of dlbcl
-
3:20
the current standard of care in cml and insights into the use of first- and second-generation tkis
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
2:46
transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:15
personalized medicine for dlbcl
-
2:10
ngs: changes in cll management
-
0:42
targeted therapies for dlbcl treatment
-
1:16
current and future advancements in the treatment of cll
-
1:19
cll treatment: a look into the future
-
2:49
assessing parameters and standardising biomarker detection in cll
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
3:19
supportive care in al amyloidosis